$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000162828019008787 Filed on July 18, 2019

Income Statement

Concept	2019 Q2	2018 Q2
Revenue	$2.355M	$3.752M
YoY Change	-37.23%	-12.96%
Cost Of Revenue	$3.144M	$1.950M
YoY Change	61.19%	-26.11%
Gross Profit	-$789.1K	$1.801M
YoY Change	-143.81%	7.82%
Gross Profit Margin	-33.51%	48.01%
Selling, General & Admin	$2.939M	$3.371M
YoY Change	-12.84%	-19.04%
% of Gross Profit		187.17%
Research & Development	$1.035M	$1.617M
YoY Change	-35.99%	84.24%
% of Gross Profit		89.76%
Depreciation & Amortization	$80.00K	$80.00K
YoY Change	0.0%	14.29%
% of Gross Profit		4.44%
Operating Expenses	$3.973M	$4.988M
YoY Change	-20.35%	-1.07%
Operating Profit	-$4.763M	-$3.187M
YoY Change	49.43%	-5.47%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.400M	$10.00K
YoY Change	13903.38%
Pretax Income	-$3.360M	$570.0K
YoY Change	-689.47%	-117.59%
Income Tax
% Of Pretax Income
Net Earnings	-$3.362M	$573.9K
YoY Change	-685.82%	-117.73%
Net Earnings / Revenue	-142.79%	15.3%
Basic Earnings Per Share	-$0.37	$0.08
Diluted Earnings Per Share	-$0.37	$0.04
COMMON SHARES
Basic Shares Outstanding	904.8K shares	7.330M shares
Diluted Shares Outstanding	904.8K shares	13.92M shares

Balance Sheet

Concept	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.960M	$7.110M
YoY Change	-30.24%	96.95%
Cash & Equivalents	$4.958M	$7.109M
Short-Term Investments
Other Short-Term Assets	$1.100M	$690.0K
YoY Change	59.42%	-59.88%
Inventory	$2.063M	$2.424M
Prepaid Expenses
Receivables	$726.7K	$1.114M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$8.849M	$11.34M
YoY Change	-21.96%	45.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$289.5K	$430.7K
YoY Change	-32.79%	-3.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.00K	$40.00K
YoY Change	-25.0%	-71.43%
Total Long-Term Assets	$1.965M	$468.8K
YoY Change	319.15%	-20.39%
TOTAL ASSETS
Total Short-Term Assets	$8.849M	$11.34M
Total Long-Term Assets	$1.965M	$468.8K
Total Assets	$10.81M	$11.81M
YoY Change	-8.42%	40.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.017M	$799.8K
YoY Change	27.17%	5.48%
Accrued Expenses	$3.081M	$1.974M
YoY Change	56.07%	13.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.840M	$4.087M
YoY Change	18.43%	11.36%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.120M
YoY Change
Total Long-Term Liabilities	$1.120M	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.840M	$4.087M
Total Long-Term Liabilities	$1.120M	$0.00
Total Liabilities	$5.957M	$4.087M
YoY Change	45.76%	10.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$192.3M	-$189.3M
YoY Change	1.58%	2.35%
Common Stock	$978.00	$736.00
YoY Change	32.88%	346.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.858M	$7.722M
YoY Change
Total Liabilities & Shareholders Equity	$10.81M	$11.81M
YoY Change	-8.42%	40.86%

Cashflow Statement

Concept	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$3.362M	$573.9K
YoY Change	-685.82%	-117.73%
Depreciation, Depletion And Amortization	$80.00K	$80.00K
YoY Change	0.0%	14.29%
Cash From Operating Activities	-$2.240M	$1.120M
YoY Change	-300.0%	-134.36%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$100.0K
YoY Change	-90.0%	150.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$10.00K	-$100.0K
YoY Change	-90.0%	150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00K	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-2.240M	1.120M
Cash From Investing Activities	-10.00K	-100.0K
Cash From Financing Activities	10.00K	0.000
Net Change In Cash	-2.240M	1.020M
YoY Change	-319.61%	-131.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.240M	$1.120M
Capital Expenditures	-$10.00K	-$100.0K
Free Cash Flow	-$2.230M	$1.220M
YoY Change	-282.79%	-137.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9781755	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	NeuroMetrix, Inc.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	64026	USD
	dei	Trading Symbol TradingSymbol	NURO
CY2018Q4	nuro	Accrued Relocation Costs AccruedRelocationCosts	0	USD
CY2019Q2	nuro	Accrued Relocation Costs AccruedRelocationCosts	100000	USD
CY2018Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	1101658	USD
CY2019Q2	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	741607	USD
CY2018Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	171000	USD
CY2019Q2	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	380000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2236633	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3081192	USD
CY2018Q2	nuro	Collaboration Income CollaborationIncome	3749999	USD
	nuro	Collaboration Income CollaborationIncome	8505704	USD
CY2019Q2	nuro	Collaboration Income CollaborationIncome	1381818	USD
	nuro	Collaboration Income CollaborationIncome	7116667	USD
CY2018Q4	nuro	Contract Manufacturer ContractManufacturer	160000	USD
CY2019Q2	nuro	Contract Manufacturer ContractManufacturer	590000	USD
CY2018Q4	nuro	Deferred Collaboration Income DeferredCollaborationIncome	1956522	USD
CY2019Q2	nuro	Deferred Collaboration Income DeferredCollaborationIncome	0	USD
CY2019Q2	nuro	Facility Relocation Costs FacilityRelocationCosts	225000	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-645938	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-360051	USD
CY2018Q2	nuro	Operating Lease Discount OperatingLeaseDiscount	606640	USD
CY2018Q2	nuro	Operating Leases Future Minimum Payments Duein Seven Years OperatingLeasesFutureMinimumPaymentsDueinSevenYears	117431	USD
CY2018Q2	nuro	Operating Leases Future Minimum Payments Duein Six Years OperatingLeasesFutureMinimumPaymentsDueinSixYears	165785	USD
CY2019Q2	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	294264	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
CY2018Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2019Q2	nuro	Technology Fees TechnologyFees	450000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1298084	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1017094	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1082957	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	726670	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	391000	USD
CY2019Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	566000	USD
CY2018Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	223756	USD
CY2019Q2	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	162990	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197113646	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197184936	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	371917	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	925400	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	861153	shares
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5858005	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6512894	shares
CY2018Q4	us-gaap	Assets Assets	13991880	USD
CY2019Q2	us-gaap	Assets Assets	10814277	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	11586165	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	8849313	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6780429	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	307420	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	332049	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4958058	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4043681	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7108915	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6780429	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4958058	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3065234	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1822371	USD
CY2019Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	454781	shares
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7380463	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9781755	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7380463	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9781755	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	738	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	978	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	1950304	USD
	us-gaap	Cost Of Revenue CostOfRevenue	4905564	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	3143787	USD
	us-gaap	Cost Of Revenue CostOfRevenue	5468018	USD
CY2018Q2	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	297858	USD
	us-gaap	Depreciation Depreciation	140989	USD
	us-gaap	Depreciation Depreciation	107494	USD
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2019Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	139588	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M23D
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1170634	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2974777	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1564555	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3184045	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	1801264	USD
	us-gaap	Gross Profit GrossProfit	3788994	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	-789104	USD
	us-gaap	Gross Profit GrossProfit	9600	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	66480	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-287260	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1288332	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-356287	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-93651	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	416745	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1956522	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	281617	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1207451	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-609358	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	239749	USD
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6584674	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6980585	shares
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1094190	USD
CY2019Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	836997	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	2861864	USD
CY2019Q2	us-gaap	Inventory Net InventoryNet	2063431	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1767674	USD
CY2019Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1226434	USD
CY2019Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2181819	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	2595884	USD
CY2018Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2306314	USD
CY2018Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	315609	USD
CY2018Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	165785	USD
CY2018Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	247347	USD
CY2018Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	653164	USD
CY2018Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	641193	USD
CY2018Q4	us-gaap	Liabilities Liabilities	7894069	USD
CY2019Q2	us-gaap	Liabilities Liabilities	5956627	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13991880	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10814277	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6592897	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4839893	USD
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2019-09-30
CY2019Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2500000	USD
CY2019Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	2300000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7497	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-130816	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7587	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3196050	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1822281	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	573928	USD
	us-gaap	Net Income Loss NetIncomeLoss	1740180	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-3362191	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1311684	USD
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	573928	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1740180	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3362191	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1311684	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	4988349	USD
	us-gaap	Operating Expenses OperatingExpenses	10576797	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	3973425	USD
	us-gaap	Operating Expenses OperatingExpenses	8473284	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q2	us-gaap	Other Income OtherIncome	11014	USD
	us-gaap	Other Income OtherIncome	22279	USD
CY2019Q2	us-gaap	Other Income OtherIncome	18520	USD
	us-gaap	Other Income OtherIncome	35333	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3187085	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6787803	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4762529	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8463684	USD
CY2018Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	582940	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	577460	USD
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	582940	USD
CY2018Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1116734	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1301172	USD
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1116734	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1968062	USD
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1645668	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	133580	USD
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	146262	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q2	us-gaap	Other Operating Income OtherOperatingIncome	3761013	USD
	us-gaap	Other Operating Income OtherOperatingIncome	8527983	USD
CY2019Q2	us-gaap	Other Operating Income OtherOperatingIncome	1400338	USD
	us-gaap	Other Operating Income OtherOperatingIncome	7152000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	130816	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7587	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	860915	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1101154	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	30314	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	29824	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	7497	USD
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	129837	USD
CY2019Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	103000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	407339	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	289472	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1616863	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2896427	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1034921	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1890002	USD
CY2019Q2	us-gaap	Restructuring Charges RestructuringCharges	2300000	USD
CY2019Q2	us-gaap	Restructuring Charges RestructuringCharges	2300000	USD
CY2019Q2	us-gaap	Restructuring Reserve RestructuringReserve	257258	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191016591	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-192328275	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-192300000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3751568	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2354683	USD
	us-gaap	Revenues Revenues	8694558	USD
	us-gaap	Revenues Revenues	5477618	USD
CY2018Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2200852	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4705593	USD
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1373949	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3399237	USD
CY2019Q2	us-gaap	Severance Costs1 SeveranceCosts1	224773	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	371917	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	64026	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7497	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	5017389	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	7721608	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	6097811	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	4857650	USD
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13915153	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13820363	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9048235	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8396249	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7330479	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6839778	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9048235	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8396249	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-19-008787-index-headers.html	Edgar Link	pending
0001628280-19-008787-index.html	Edgar Link	pending
0001628280-19-008787.txt	Edgar Link	pending
0001628280-19-008787-xbrl.zip	Edgar Link	pending
a10q6302019document.htm	Edgar Link	pending
a10q6302019ex101.htm	Edgar Link	pending
a10q6302019ex311.htm	Edgar Link	pending
a10q6302019ex312.htm	Edgar Link	pending
a10q6302019ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nuro-20190630.xml	Edgar Link	completed
nuro-20190630.xsd	Edgar Link	pending
nuro-20190630_cal.xml	Edgar Link	unprocessable
nuro-20190630_def.xml	Edgar Link	unprocessable
nuro-20190630_lab.xml	Edgar Link	unprocessable
nuro-20190630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2019 Q2 Form 10-Q Financial Statement

#000162828019008787 Filed on July 18, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2019 Q2 Form 10-Q Financial Statement

#000162828019008787 Filed on July 18, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro